Early Valve Thrombosis Management After Successful Transcatheter Tricuspid Valve-in-Valve Implantation
© 2022 Published by Elsevier on behalf of the American College of Cardiology Foundation..
Transcatheter tricuspid valve-in-valve implantation is a critical option in high risk bioprosthetic tricuspid valve dysfunction. In this case report, balloon-expandable transcatheter heart valve was implanted successfully into the tricuspid valve and early thrombosis was managed successfully. (Level of Difficulty: Intermediate.).
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:5 |
|---|---|
| Enthalten in: |
JACC. Case reports - 5(2023) vom: 04. Jan., Seite 101584 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Babur Guler, Gamze [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Revised 15.01.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.jaccas.2022.07.042 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM351474528 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM351474528 | ||
| 003 | DE-627 | ||
| 005 | 20231226051442.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jaccas.2022.07.042 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1171.xml |
| 035 | |a (DE-627)NLM351474528 | ||
| 035 | |a (NLM)36636503 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Babur Guler, Gamze |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Early Valve Thrombosis Management After Successful Transcatheter Tricuspid Valve-in-Valve Implantation |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 15.01.2023 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2022 Published by Elsevier on behalf of the American College of Cardiology Foundation. | ||
| 520 | |a Transcatheter tricuspid valve-in-valve implantation is a critical option in high risk bioprosthetic tricuspid valve dysfunction. In this case report, balloon-expandable transcatheter heart valve was implanted successfully into the tricuspid valve and early thrombosis was managed successfully. (Level of Difficulty: Intermediate.) | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a ACC/AHA, American College of Cardiology/American Heart Association | |
| 650 | 4 | |a ASA, acetylsalicylic acid | |
| 650 | 4 | |a ESC, European Society of Cardiology | |
| 650 | 4 | |a IVC, inferior vena cava | |
| 650 | 4 | |a PHT, pressure half time | |
| 650 | 4 | |a TEE, transesophageal echocardiography | |
| 650 | 4 | |a TTE, transthoracic echocardiography | |
| 650 | 4 | |a TTVIV, transcatheter tricuspid valve-in-valve | |
| 650 | 4 | |a TV, tricuspid valve | |
| 650 | 4 | |a VIV, valve-in-valve | |
| 650 | 4 | |a VKA, vitamin K antagonist | |
| 650 | 4 | |a percutaneous valve | |
| 650 | 4 | |a thrombus | |
| 650 | 4 | |a transcatheter valve implantation | |
| 650 | 4 | |a tricuspid valve | |
| 700 | 1 | |a Memic Sancar, Kadriye |e verfasserin |4 aut | |
| 700 | 1 | |a Corekcioglu, Busra |e verfasserin |4 aut | |
| 700 | 1 | |a Topel, Cagdas |e verfasserin |4 aut | |
| 700 | 1 | |a Erturk, Mehmet |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t JACC. Case reports |d 2019 |g 5(2023) vom: 04. Jan., Seite 101584 |w (DE-627)NLM304093653 |x 2666-0849 |7 nnns |
| 773 | 1 | 8 | |g volume:5 |g year:2023 |g day:04 |g month:01 |g pages:101584 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jaccas.2022.07.042 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 5 |j 2023 |b 04 |c 01 |h 101584 | ||